Pay in 4 interest-free payments of $25.29 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
is a semi-synthetic erythromycin derivative used to treat mild to moderate respiratory infections
in which the two hydroxy groups of GLYCEROL are esterified with fatty acids
17(2):195-203
such as NODI and NOD2
Bronzuoli MR
Cebranopadol - CAS# 863513-91-1 suquidar is a semi-synthetic erythromycin derivativeCebranopadol, also known as GRT 6005, is a Opioid Receptor Agonist with agonistic activity at nociceptin orphanin FQ and opioid receptors. Cebranopadol displays analgesic, antiallodynic and antihyperalgesic properties in several rat models of acute nociceptive, inflammatory, cancer and neuropathic pain. In contrast to classical opioids, it has a higher analgesic potency in models of neuropathic pain than in acute nociceptive pain. Even at higher